Figure 4.
Effects of ACSM3 on the Integrin β1/AKT signaling pathway in ovarian cancer. (A) The protein expression of Integrin β1, p-AKT, AKT, cyclin D1, c-Myc, Vimentin, and E-cadherin in OV-90 cells following ACSM3 knockdown. (B) The protein expression of Integrin β1, p-AKT, AKT, cyclin D1, c-Myc, Vimentin, and E-cadherin in A2780 cells following ACSM3 overexpression. Measurement data were expressed as mean ± SD of three independent experiments. **P < 0.01 versus Lv-shRNA-NC; ##P < 0.01 versus Lv-Vector.